Sildenafil Tablet, Film Coated
Product Images NDC 68071-4617

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Sildenafil (NDC 68071-4617). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

68071 4617 3 H40

Sildenafil 100 mg tablets label from NuCare Pharmaceuticals, Inc. The label indicates a package size of 30 film-coated tablets for oral use. It includes an NDC number 68071-4617-3 and a product number R1789030. The label displays storage instructions to keep at controlled temperature 68-77°F and a warning to keep out of reach of children. Manufacturer details include Hetero Labs Limited, Hyderabad, India.*

FDA Label Image

Camberlogo1 (Camberlogo1)

FDA Label Image

Camberlogo2 (Camberlogo2)

FDA Label Image

Sildenafilfigure7 (Sildenafilfigure7)

A bar chart illustrating the percentage of patients reporting improvement across different treatment groups. The groups include Placebo, Sildenafil Citrate 25 mg Tablets, 50 mg Tablets, and 100 mg Tablets, with improvement percentages increasing from placebo to the highest dose of Sildenafil Citrate.*

FDA Label Image

Sildenafilfigure1 (Sildenafilfigure1)

A line graph comparing systolic blood pressure (mmHg) over 24 hours post-dose between Sildenafil 100 mg and placebo. The x-axis shows time in hours post dose, and the y-axis shows systolic blood pressure changes. The graph includes two lines representing Sildenafil and placebo responses over time.*

FDA Label Image

Sildenafilfigure2 (Sildenafilfigure2)

A line graph showing the change in SBP (systolic blood pressure, mmHg) over time in hours after dosing. The graph compares two treatments: Nicardipine & Placebo versus Nicardipine & Sildenafil 100 mg. The x-axis represents time postdose in hours, and the y-axis shows the change in SBP in mmHg.*

FDA Label Image

Sildenafilfigure3 (Sildenafilfigure3)

A line graph showing the change in mean systolic blood pressure over time in hours with two plotted lines representing Doxazosin with placebo and Doxazosin with Sildenafil 50 mg. The x-axis represents time postdose in hours, and the y-axis shows the change in mean systolic blood pressure.*

FDA Label Image

Sildenafilfigure4 (Sildenafilfigure4)

A line graph comparing the effects over time after dosing (0 to 8 hours) of Doxazosin with Sildenafil 100 mg versus Doxazosin with Placebo. The y-axis appears to represent a measurement in mmHg, and both treatments show a decrease initially with gradual changes over the time period.*

FDA Label Image

Sildenafilfigure5 (Sildenafilfigure5)

A line graph showing plasma concentration (ng/mL) of a substance over time (hours) after dosing, comparing treatment with a commercial tablet. The graph indicates peak concentration occurs shortly after dosing, followed by a gradual decline over 24 hours.*

FDA Label Image

Sildenafilfigure6a (Sildenafilfigure6a)

A bar chart displaying the percentage of patients at endpoint versus baseline score. The chart features multiple grouped bars representing different categories labeled 0 through 5, showing trends in patient distribution across baseline scores. The vertical axis shows percentage values from 0 to 80%, and the horizontal axis shows baseline scores from 0 to 5.*

FDA Label Image

Sildenafilfigure6b (Sildenafilfigure6b)

A bar chart depicting the percentage of patients at endpoint categorized by baseline score, ranging from 0 to 5. The legend indicates groups labeled 00 through 05 with different shading patterns. The x-axis represents the baseline score, and the y-axis shows the percentage of patients at the endpoint.*

FDA Label Image

Sildenafilheterologo1 (Sildenafilheterologo1)

FDA Label Image

Sildenafilheterologo2 (Sildenafilheterologo2)

FDA Label Image

Sildenafilstructure (Sildenafilstructure)

Chemical structure of Sildenafil depicted with its molecular framework, including characteristic nitrogen and oxygen atoms and functional groups. The structure shows the core bicyclic system and attached groups defining the active pharmaceutical ingredient.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.